Product sales for the three months ended September 30, 2024 was $597,677 compared to $3,631 in the three months ended September 30, 2023. During the third quarter, the Company recorded $594,705 from ...
BioStem made the announcement on November 20, 2024. The company indicated that the acquisition of revyveTM Antimicrobial Wound Gel reflects BioStem’s continued commitment to building a ...
From the sports industry to social media and marketing, studying a Master in Management degree could help you fast-track to leadership in a range of industries If you’re looking to advance to a ...
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its ...
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company", "Kane Biotech") announces today that President & CEO, Marc Edwards and Dr. Robert Huizinga ...
(TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its revyve™ Antimicrobial Wound Gel as a Class 2 Medical Device ... of ...
The investment follows a successful initial round of funding and reflects growing confidence in DEBx Medical's innovative approach to chronic wound management, specifically through its breakthrough ...
The investment follows a successful initial round of funding and reflects growing confidence in DEBx Medical’s innovative approach to chronic wound management, specifically through its breakthrough ...
Many people reach for Neosporin for cuts, minor wounds, burns, and scrapes. It's an antibacterial ointment that effectively treats some injuries, but should not be used on every type of open wound.